Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Longer-term organ abnormalities confirmed in some post-hospitalised COVID patients

COVID-19 research CVM Department General OCMR Research

A study looking at the longer-term impact of COVID-19 has found that nearly a third of patients displayed abnormalities in multiple organs five months after infection, some of which have been shown through previous work to be evidence of tissue damage.

Clinical trial investigating potential investigational treatment for relief of fatigue in people with long COVID reports results

COVID-19 research CVM Department General Publication Research

Research led by Associate Professor Betty Raman finds positive results from a Phase 2 clinical trial of an investigational treatment against long COVID fatigue.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

AMIIC COVID-19 research CVM

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.

Novel all-in-one vaccine developed to tackle future coronavirus threats

COVID-19 research HIU COVID-19 research MRC HIU MRC TIDU MRC WIMM Publication Research

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

Building on the pandemic experience

COVID-19 research NDCLS

Dr Susie Shapiro on her experience of working through the pandemic, and how she is building on it.

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

COVID-19 research HIU COVID-19 research MRC HIU MRC TIDU MRC WIMM

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.

COVID-19 patients continue to experience symptoms six months after infection

COVID-19 research CVM OCMR

Study investigating the long-term impact of moderate to severe COVID-19 finds that a large proportion of COVID-19 patients previously admitted to hospital continue to experience intrusive symptoms six months following infection.

COVID-19 recovery project nominated for HSJ award

Awards COVID-19 research CVM OCMR

Updated: the project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine was 'highly commended' at the Health Service Journal Awards 2021.

DNA breakthrough could help identify why some people are more affected by Covid-19

COVID-19 research MRC MHU MRC WIMM

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk